OncoHost

OncoHost

OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes. Its proprietary PROphet® platform is a plasma-based, proteomic pattern analysis tool whose initial offering in non-small cell lung cancer (NSCLC) uses a single blood sample to guide first-line immunotherapy decision-making, with a significant effect on overall survival. Backed by an experienced team and a large-scale clinical trial with over 40 sites and 1,700 patients worldwide, OncoHost is well-positioned to advance precision diagnostics and biomarker development to the next stage

Yes

Lung Cancer, Metastatic Disease, Biomarkers, Biotechnology, Immunotherapy, Personalized Medicine, Artificial Intelligence